申请人:HOFFMANN LA ROCHE
公开号:WO2019043214A1
公开(公告)日:2019-03-07
The present invention provides compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. Present compounds are thus useful for the treatment of various cancers.
本发明提供了一种与广泛表达的E3连接酶蛋白Cereblon(CRBN)结合并改变CRBN E3泛素连接酶复合物底物特异性的化合物,导致内在下游蛋白的降解。因此,目前的化合物对于治疗各种癌症是有用的。